<span item_type="fundamental" item_id="b990c7b1da0444cc64b517fc400cb1ab" counter_id="ST/US/GPATW" env="prod"></span><span item_type="announcement" item_id="516048084659541121" env="prod"></span><p>EPS: As of FY2025 Q1, the actual value is USD 0.08.</p><p></p><h3>Segment Revenue</h3><ul><li>The company has not generated any operating revenues as of March 31, 2025, as it is a blank check company focused on completing a business combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1834526/000121390025043106/ea0241545-10q_gpact3.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income</strong>: For the three months ended March 31, 2025, the company reported a net income of $2,907,329, compared to a net loss of $59,738 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1834526/000121390025043106/ea0241545-10q_gpact3.htm"></span></li><li><strong>General and Administrative Expenses</strong>: These expenses increased to $200,052 for the three months ended March 31, 2025, from $59,738 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1834526/000121390025043106/ea0241545-10q_gpact3.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: For the three months ended March 31, 2025, net cash used in operating activities was - $151,938, compared to - $48,011 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1834526/000121390025043106/ea0241545-10q_gpact3.htm"></span></li><li><strong>Cash</strong>: As of March 31, 2025, the company had cash of $376,572, down from $483,572 as of December 31, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1834526/000121390025043106/ea0241545-10q_gpact3.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Interest Earned on Marketable Securities</strong>: The company earned $3,107,381 in interest from marketable securities held in the Trust Account for the three months ended March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1834526/000121390025043106/ea0241545-10q_gpact3.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company plans to complete a business combination using the funds from its Initial Public Offering and private placement warrants. It has until May 13, 2026, to consummate this business combination, failing which it will undergo liquidation.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1834526/000121390025043106/ea0241545-10q_gpact3.htm"></span></li><li><strong>Liquidity and Going Concern</strong>: Management plans to address liquidity concerns through a business combination. If not consummated by May 13, 2026, the company will face mandatory liquidation, raising substantial doubt about its ability to continue as a going concern.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1834526/000121390025043106/ea0241545-10q_gpact3.htm"></span></li></ul>

GP-ACT III ACQUISITION CORP C/WTS 13/05/2029 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD 0.08